PF-Atlas › Clinical Trials › NCT00004440

Study of Ibuprofen to Preserve Lung Function in Patients With Cystic Fibrosis

ibuprofen · Not specified

Registry ID

NCT00004440

Phase

Not specified

Status

Completed

Drug / intervention

ibuprofen

Sponsor

FDA Office of Orphan Products Development

Start

1996-08

Enrollment

About this trial

OBJECTIVES: I. Determine the effect of different doses of ibuprofen on neutrophil (polymorphonuclear leukocyte; PMN) delivery to a mucosal surface (the oral mucosa) in patients with cystic fibrosis and healthy controls. II. Determine the duration of effect (and possible rebound effect) of ibuprofen on PMN delivery to a mucosal surface in these patients.

View NCT00004440 on ClinicalTrials.gov →

Explore related

All ibuprofen trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT00004440 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.